机构:[1]Department of Clinical Epidemiology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China[2]Department of Dermatology,Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, No.111Da De Road, Guangdong 510120, China大德路总院皮肤科大德路总院皮肤科广东省中医院[3]Department of Dermatology,University of California, San Francisco, USA[4]Department of Sleep and MentalDisorder, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou,China广东省中医院深圳市中医院深圳医学信息中心心理睡眠科大德路总院[5]Department of Evidence-based Medicine and Clinical Research ofChinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, theSecond Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou, China广东省中医院中医循证医学与临床研究服务团队科研大德路总院[6]Michigan Association of Acupuncture and OrientalMedicine, The Lotus Center of Ann Arbor, Ann Arbor, USA[7]Department ofNeurology, Lutheran Medical Center, New York, USA[8]Key Laboratory ofClinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, No.55, Nei Huan WestRoad, University City, Panyu District, Guangzhou, China.
Background: Dermatological disease significantly affects patient's health-related quality of life (HrQoL). Skindex is one of the most frequently used dermatology-specific HrQoL measures. Currently no Chinese version of Skindex is available. The aim of this study was to translate and culturally adapt Skindex-29 and Skindex-16 into Chinese, and to evaluate their reliability and validity. Methods: Translation and cultural adaption were performed following guidelines for cross-cultural adaption of health-related quality of life measures. Subsequently, a cross-sectional study was conducted in which patients with dermatological disease (n = 225) were enrolled. The Chinese version of Skindex-29 and Skindex-16 and Dermatology Life Quality Index (DLQI) were completed. Reliability was evaluated with internal consistency using Cronbach's alpha. Validity was evaluated using known-groups validity, convergent validity and factor structure validity. Results: There were both seven items of Skindex-29 and Skindex-16 requiring a second forward-and backward-translation to achieve the final satisfactory Chinese version. The internal consistency reliability was high (range of Cronbach's alpha for the scales of Skindex-29 0.85-0.97, Skindex-16 0.86-0.96). Known-group validity was demonstrated by higher scores from patients with inflammatory dermatosis than from patients with isolated skin lesions (P < 0.05). Evidence of factor structure validity of the Skindex-29 and Skindex-16 was demonstrated by both exploratory factor analysis that accounted for 68.66% and 77.78% of the total variance, respectively, and confirmatory factor analysis with acceptable fitness into the expected three-factor structure. Conclusion: This study has developed semantically equivalent translations of Skindex-29 and Skindex-16 into Chinese. The evaluation of the instruments' psychometric properties shows they have substantial evidence of reliability and validity for use as HrQoL instruments in Chinese patients with dermatological disease.
基金:
National Key Technology R&D Program for the 12th Five-year Plan of Ministry of Science and Technology, ChinaNational Key Technology R&D Program [2013BAI02B03]; Financial Industry Technology Research and Development Program of Guangdong Province, China [2011(285)05]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类|4 区医学
小类|3 区卫生保健与服务
最新[2025]版:
大类|2 区医学
小类|2 区卫生保健与服务2 区卫生政策与服务
JCR分区:
出版当年[2012]版:
Q1HEALTH POLICY & SERVICESQ2HEALTH CARE SCIENCES & SERVICES
最新[2023]版:
Q1HEALTH CARE SCIENCES & SERVICESQ1HEALTH POLICY & SERVICES
第一作者机构:[1]Department of Clinical Epidemiology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
通讯作者:
通讯机构:[2]Department of Dermatology,Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, No.111Da De Road, Guangdong 510120, China[8]Key Laboratory ofClinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, No.55, Nei Huan WestRoad, University City, Panyu District, Guangzhou, China.
推荐引用方式(GB/T 7714):
He Zehui,Lu Chuanjian,Chren Mary-Margaret,et al.Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16[J].HEALTH AND QUALITY OF LIFE OUTCOMES.2014,12:doi:10.1186/s12955-014-0190-4.
APA:
He, Zehui,Lu, Chuanjian,Chren, Mary-Margaret,Zhang, Zhongzhao,Li, Yan...&Li, Guo-Zheng.(2014).Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.HEALTH AND QUALITY OF LIFE OUTCOMES,12,
MLA:
He, Zehui,et al."Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16".HEALTH AND QUALITY OF LIFE OUTCOMES 12.(2014)